Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 538-545

  Foda, Hussein D ^a   George, Suni ^b   Conner, Cathleen ^b   Drews, Michelle ^b   Tompkins, David C ^b   Zucker, Stanley ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE; GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BASEMENT MEMBRANE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; UMBILICAL VEIN;

CELL MEMBRANE; CONCANAVALIN A; DRUG COMBINATIONS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATINASES; HUMANS; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0030045799     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, and Engler JA (1993). Matrix metalloproteinases: A review. Grit Rev Oral Biol Med 4:197-250.
2. Crabbe T, Zucker S, Cockett MI, Willenbrock F, Tickle S, O'Connell JP, Scothern JM, Murphy G, and Docherty AJP (1994). Mutation of the active site glutamic acid of human gelatinase A: Effects of latency, catalysis and the binding of tissue inhibitor of metalloproteinases-1 (TIMP-1). Biochemistry 33:6684-6690.
3. Davies B, Brown PD, East N, Crimmin MJ, and Balkwill FR (1993). A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53:2087-2091.
4. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, and Stetler-Stevenson WG (1992). Domain structure of human 72-kd gelatinase/ type IV collagenase. J Biol Chem 267:15389-15405.
5. Gordon PB, Sussman II, and Hatcher VB (1983). Long-term culture of human endothelial cells. In Vitro 19:661-671.
6. Hanemaaijer R, Koolwijk P, Clercq L, De Vree WJA, and Van Hinsbergh VWM (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem J 296:803-809.
7. Jaffe EA (1980). Culture of human endothelial cells. Transplant Proc 12:49-53.
8. Kleiner DE, Tuuttila A, Tryggvason K, and Stetler-Stevenson WG (1993). Stability analysis of latent and active 72-kd type IV collagenase: The role of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochemistry 32:1583-1592.
9. Matrisian LM (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125.
10. Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, and Zucker S (1992). Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma. Connect Tissue Res 28:213-230.
11. Mulligan MS, Hevel JM, Marietta MA, and Ward PA (1991). Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88:6338-6342.
12. Murphy G, and Docherty JP (1992). The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120-125.
13. Murphy G, Willenbrock F, Crabbe T, Ward R, Atkinson S, O'Connel J, and Docherty A (1994). Regulation of matrix metaltoproteinase activity. Ann N Y Acad Sci 732:31-41.
14. Murphy G, Willenbrock F, Ward RV, Cockett Ml, Eaton D, and Docherty AJP (1992). The C-terminal domain of 72 kd gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interaction with tissue inhibitors of metalloproteinases. Biochem J 283:637-641.
15. Nishizuka Y (1984). The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698.
16. Overall CM, and Sodek J (1990). Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J Biol Chem 265:21141-21151.
17. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
18. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, and Liotta LA (1989). The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353-1356.
19. Sudbeck BD, Parks WC, Welgus HG, and Pentland AP (1994). Collagen-stimulated induction of keratinocyte collagenase is mediated via tyrosine kinase and protein kinase C activities. J Biol Chem 269:30022-30029.
20. Ward RV, Atkinson SJ, Reynolds JJ, and Murphy G (1994). Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem J 304:263-269.
21. Will H, and Hinzmann B (1995). cDNA sequence and mRNA distribution of novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608.
22. Woessner JF (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154.
23. Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, and Bahou WF (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells: Physiological regulation of angiogenesis. J Biol Chem 270:23730-23738.